Human papilloma virus vaccines: Current scenario - Wikidata - awgldk - TriplyDB

Human papilloma virus vaccines: Current scenario

Human papilloma virus vaccines: Current scenario

http://www.wikidata.org/entity/Q35366075

about

Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains Safety of human papillomavirus vaccines: a review.Pediatricians' perceptions of vaccine effectiveness and safety are significant predictors of vaccine administration in India.Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.Human papillomavirus: current status and issues of vaccination.Cervical cancer control in Latin America: A call to action.Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in Ethiopia and the Sudan.Cancer screening and prevention in low-resource settings.Designing of CD8 and CD8-overlapped CD4 epitope vaccine by targeting late and early proteins of human papillomavirus

P2860

Q28972497-0B47130E-AF6A-4C03-9BB2-F85FF1A38F18 Q33162724-EF4A62D3-A3F1-4671-8581-EB1651406670 Q33910984-F1F27F65-BF55-4534-95D2-2164608C7A0A Q34729962-9BDE2D75-7EFD-4462-9FCF-B53C7A6AB7C1 Q38136127-AA9DBCC4-F581-44BA-9CAC-D6CE2F64A07F Q38670183-00BA4756-6B9E-444E-8773-7347F7245FCA Q43454820-EA26E62D-B000-4F56-8A0C-95B977463883 Q53253182-701732E8-3E08-4D94-8A44-60318E093FAB Q57484891-362BBE26-1201-4482-BE90-96916DCDBA5C

P2860

Human papilloma virus vaccines: Current scenario

http://www.wikidata.org/entity/Q35366075

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Human papilloma virus vaccines: Current scenario

@ast

Human papilloma virus vaccines: Current scenario

@en

type

label

Human papilloma virus vaccines: Current scenario

@ast

Human papilloma virus vaccines: Current scenario

@en

prefLabel

Human papilloma virus vaccines: Current scenario

@ast

Human papilloma virus vaccines: Current scenario

@en

P1433

Q35366075-34565B2D-09C1-464F-924D-6CA838D6B54C

P1476

Q35366075-FF7A2F72-BA0A-48F6-94DF-CF7329371E42

P2093

Q35366075-4532DFFA-66DE-488A-B56E-F40CDC8AC873

P2860

Q35366075-002AC618-7F27-44ED-BF02-AAD8871FEFB1

Q35366075-005E02F7-6E7B-430A-954A-8EF0E709B34A

Q35366075-1292880F-CB34-453F-AEA2-8D8FF8027989

Q35366075-19656E55-1698-4869-987A-AB2328F4D543

Q35366075-1D3AD1DB-D6AA-4253-AF78-9582A28BBF12

Q35366075-1E669B19-3775-4C80-A406-1355C40071F8

Q35366075-288ADE38-1D51-4FCE-84B2-27C7BAEE293A

Q35366075-298ACC6E-0358-4F2E-8ACD-8562FFEC2B2C

Q35366075-2CCBA687-9110-4005-84C4-28D4158C23C3

Q35366075-2EF5EBD7-4720-4669-BE71-DD87F13C297D

P304

Q35366075-DE73E5DC-FEAC-4EC8-99AE-0A87BE02600F

P31

Q35366075-2B97ED57-B55A-4DF2-A935-145F63B6F09A

P356

Q35366075-B34E5FD1-21B4-46DD-999C-1D12D3E3963D

Q35366075-E81F116B-BD91-418A-9092-E54EF5D3D4E7

P433

Q35366075-11EE096F-5AD7-4E98-9978-A5F47157797B

P478

Q35366075-EFDF571D-B3C2-45DE-A2EE-14927B62DC2D

P50

Q35366075-7A1AA5FB-4F34-47CE-9B8A-221AFBBFD626

P577

Q35366075-44E13FD6-7918-4A2C-B584-35C03210F237

P5875

Q35366075-8C2400CE-703A-40BC-9A29-AA051B7ACD9F

P698

Q35366075-460AD301-9553-4ABC-B678-9D8CF03CC622

P932

Q35366075-5ED77802-9F0B-47C4-92D0-773B2A1CA066

P356

0253-7184.85409

2589-0557.85409

P1433

Indian Journal of Sexually Transmitted Diseases and AIDS

P1476

Human papilloma virus vaccines: Current scenario

@en

P2093

Deepika Pandhi

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Global cancer statistics, 2002

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.

P304

75-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0253-7184.85409

http://www.w3.org/2001/XMLSchema#string

10.4103/2589-0557.85409

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Sidharth Sonthalia

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51737305

http://www.w3.org/2001/XMLSchema#string

P698

22021967

http://www.w3.org/2001/XMLSchema#string

P932

3195186

http://www.w3.org/2001/XMLSchema#string